Odyssey Therapeutics

Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. The company's integrated drug-hunting engine is designed to accelerate drug discovery by unlocking targets with great potential and minimizing attrition.

Odyssey Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $23.4B in funding across 48 round(s). With a team of 11-50 employees, Odyssey Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Odyssey Therapeutics, raised $101.0M. Discover more about their projects, partnerships, and impact on our platform.